Key Takeaways:
Two of the world's top investor rights law firms have now filed class-action lawsuits against PomDoctor Ltd. (NASDAQ: POM), reminding investors with losses over $100,000 of an upcoming deadline. The lawsuits concern investors who purchased securities between October 9, 2025, and December 11, 2025.
According to the lawsuit filed by Rosen Law Firm, the defendants are accused of making false or misleading statements and failing to disclose a fraudulent stock promotion scheme. The firm alleges the scheme involved social media misinformation and the impersonation of financial professionals to artificially inflate the stock price.
The filings detail claims that company insiders or their affiliates used offshore and nominee accounts to sell shares in a coordinated manner during the period of price inflation. PomDoctor's public statements and risk disclosures allegedly omitted any mention of these false rumors or the artificial trading activity that was driving the stock's price. As a result, the lawsuits claim that positive statements about PomDoctor's business and prospects were materially misleading.
Investors who wish to serve as lead plaintiff in the class action must move the Court no later than April 7, 2026. A lead plaintiff is a representative party that acts on behalf of other class members. Investors may be entitled to compensation without payment of any out-of-pocket fees through a contingency fee arrangement.
The lawsuits allege a coordinated scheme to defraud investors, putting the stock's past performance during the class period under intense scrutiny. Investors will be watching for the court's decision on class certification and any formal response from PomDoctor Ltd. regarding the allegations.
This article is for informational purposes only and does not constitute investment advice.
